Regulatory Affairs promotional review teams
Pre-screen materials before formal MLR submission. Catch structural and precedent-based issues while there's still time to revise, instead of during a committee meeting.
Legal promotional review teams
Get a structured, citable regulatory risk read to inform legal risk assessment alongside contract, liability, and IP review. This is not legal advice — it's a regulatory input your legal review can weigh.
Medical, Legal, and Regulatory (MLR) committees
Standardize the criteria reviewers are applying. Reduce the subjective disagreement that stalls committee cycles, and give every reviewer the same evidence base to work from.
Medical affairs teams
Check scientific claims and data presentation against precedent and substantiation standards before submission, particularly where efficacy or comparative claims are involved.
Commercial and marketing review teams
Understand regulatory risk earlier in creative development — before a concept is fully produced and rework becomes expensive.
Promotional agencies supporting pharma clients
Build regulatory risk awareness into the creative process itself. Fewer late-stage client rejections, faster approval cycles.
Compliance teams
Maintain a defensible, citation-backed audit trail of promotional review decisions and rationale across the portfolio.
Talk to us about your workflow.
Tell us how your team reviews promotional material today, and we'll show you where OPDP Intelligence fits.